Walleye Capital’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.28M Buy
741,142
+510,633
+222% +$4.87M 0.04% 657
2025
Q4
$2.8M Buy
230,509
+169,668
+279% +$2.06M 0.02% 1590
2025
Q3
$711K Buy
+60,841
New +$728K 0.01% 2343
2025
Q1
Sell
-10,548
Closed -$90.1K 4930
2024
Q4
$90.1K Buy
+10,548
New +$103K ﹤0.01% 4180
2024
Q2
Sell
-82,058
Closed -$747K 5907
2024
Q1
$747K Buy
+82,058
New +$582K 0.01% 2855
2023
Q3
Sell
-43,665
Closed -$225K 5484
2023
Q2
$225K Buy
43,665
+24,854
+132% +$148K ﹤0.01% 3006
2023
Q1
$99.1K Buy
+18,811
New +$89.3K ﹤0.01% 2935
2022
Q2
Sell
-15,482
Closed -$77K 2632
2022
Q1
$77K Sell
15,482
-55,973
-78% -$310K ﹤0.01% 1792
2021
Q4
$498K Buy
+71,455
New +$555K 0.02% 987
2020
Q3
Sell
-34,700
Closed -$289K 935
2020
Q2
$289K Buy
34,700
+23,700
+215% +$157K 0.06% 344
2020
Q1
$55K Buy
+11,000
New +$54.3K 0.02% 678

Other funds holding OCUL